Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 106, Issue 2, 2014, Pages 351-359

  Kim, Ye An ^a   Ku, Eu Jeong ^a,b   Khang, Ah Reum ^a,c   Hong, Eun Shil ^a,d   Kim, Kyoung Min ^b   Moon, Jae Hoon ^b   Choi, Sung Hee ^a,b   Park, Kyong Soo ^a   Jang, Hak Chul ^a,b   Lim, Soo ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

Author keywords

Insulin resistance; Oral glucose tolerance test; Prediabetes; Type 2 diabetes; Cell function

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; GLYCEMIC INDEX; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; AGED; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; DISEASE COURSE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH STATUS INDICATOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; PREDIABETIC STATE; RISK;

ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEALTH STATUS INDICATORS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK;

EID: 84920578568     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.08.014     Document Type: Article

References (43)

1. Farr S.L., Hayes D.K., Bitsko R.H., Bansil P., Dietz P.M. Depression, diabetes, and chronic disease risk factors among US women of reproductive age. Prev Chron Dis 2011, 8:A119.
2. Ferrannini E., Gastaldelli A., Iozzo P. Pathophysiology of prediabetes. Med Clin N Am 2011, 95:327-339. (vii-viii).
3. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
4. Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(Suppl 1):S11-S61. American Diabetes A.
5. Unwin N., Shaw J., Zimmet P., Alberti K.G. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Med J Br Diabetic Assoc 2002, 19:708-723.
6. Tabak A.G., Herder C., Rathmann W., Brunner E.J., Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012, 379:2279-2290.
7. DeFronzo R.A., Ferrannini E., Simonson D.C. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989, 38:387-395.
8. Cherrington A.D. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 1999, 48:1198-1214.
9. DeFronzo R.A., Gunnarsson R., Bjorkman O., Olsson M., Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Investig 1985, 76:149-155.
10. Kanat M., Norton L., Winnier D., Jenkinson C., DeFronzo R.A., Abdul-Ghani M.A. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. Acta Diabetol 2011, 48:209-217.
11. Rathmann W., Kowall B., Heier M., Herder C., Holle R., Thorand B., et al. Prediction models for incident type 2 diabetes mellitusin the older population: KORA S4/F4 cohort study. Diabetic Med J Br Diabetic Assoc 2010, 27:1116-1123.
12. Wilson P.W., Meigs J.B., Sullivan L., Fox C.S., Nathan D.M., D'Agostino R.B. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham offspring study. Arch Int Med 2007, 167:1068-1074.
13. Buijsse B., Simmons R.K., Griffin S.J., Schulze M.B. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 2011, 33:46-62.
14. Schmidt M.I., Duncan B.B., Bang H., Pankow J.S., Ballantyne C.M., Golden S.H., et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005, 28:2013-2018.
15. Abdul-Ghani M.A., Williams K., DeFronzo R.A., Stern M. What is the best predictor of future type 2 diabetes. Diabetes Care 2007, 30:1544-1548.
16. Hayashi T., Boyko E.J., Sato K.K., McNeely M.J., Leonetti D.L., Kahn S.E., et al. Patterns of insulin concentration during the OGTT predict the risk of type 2 diabetes in Japanese Americans. Diabetes Care 2013, 36:1229-1235.
17. Phillips L.S., Ziemer D.C., Kolm P., Weintraub W.S., Vaccarino V., Rhee M.K., et al. Glucose challenge test screening for prediabetes and undiagnosed diabetes. Diabetologia 2009, 52:1798-1807.
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
19. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Jarvinen H., Van Haeften T., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000, 23:295-301.
20. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
21. Seltzer H.S., Allen E.W., Herron A.L., Brennan M.T. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Investig 1967, 46:323-335.
22. Utzschneider K.M., Prigeon R.L., Faulenbach M.V., Tong J., Carr D.B., Boyko E.J., et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009, 32:335-341.
23. Abdul-Ghani M.A., Tripathy D., DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006, 29:1130-1139.
24. Legro R.S., Finegood D., Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998, 83:2694-2698.
25. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
26. Hilden J., Glasziou P. Regret graphs, diagnostic uncertainty and Youden's index. Stat Med 1996, 15:969-986.
27. Mohan V., Amutha A., Ranjani H., Unnikrishnan R., Datta M., Anjana R.M., et al. Associations of beta-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians. Diabetes Technol Ther 2013, 15:315-322.
28. Shin C.S., Lee H.K., Koh C.S., Kim Y.I., Shin Y.S., Yoo K.Y., et al. Risk factors for the development of NIDDM in Yonchon County, Korea. Diabetes Care 1997, 20:1842-1846.
29. Weyer C., Tataranni P.A., Bogardus C., Pratley R.E. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2001, 24:89-94.
30. Gastaldelli A., Miyazaki Y., Matsuda M., Pettiti M., Natali A., Mari A., et al. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 2003, 46:1211-1219.
31. Alvarsson M., Wajngot A., Cerasi E., Efendic S. K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years. Diabetologia 2005, 48:2262-2268.
32. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003, 46:3-19.
33. Gerstein H.C., Santaguida P., Raina P., Morrison K.M., Balion C., Hunt D., et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007, 78:305-312.
34. Abdul-Ghani M.A., Lyssenko V., Tuomi T., DeFronzo R.A., Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia study. Diabetes Care 2009, 32:281-286.
35. Abdul-Ghani M.A., Abdul-Ghani T., Ali N., Defronzo R.A. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008, 31:1650-1655.
36. Sorkin J.D., Muller D.C., Fleg J.L., Andres R. The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 2005, 28:2626-2632.
37. Morris D.H., Khunti K., Achana F., Srinivasan B., Gray L.J., Davies M.J., et al. Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 2013, 56:1489-1493.
38. Hanefeld M., Koehler C., Fuecker K., Henkel E., Schaper F., Temelkova-Kurktschiev T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose the risk factor in impaired glucose tolerance for atherosclerosis and diabetes study. Diabetes Care 2003, 26:868-874.
39. Sjaarda L.A., Michaliszyn S.F., Lee S., Tfayli H., Bacha F., Farchoukh L., et al. HbA(1c) diagnostic categories and beta-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care 2012, 35:2559-2563.
40. Bergman R.N., Ader M., Huecking K., Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002, 51(Suppl 1):S212-S220.
41. Luzi L., DeFronzo R.A. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol 1989, 257:E241-E246.
42. Meyer J., Sturis J., Katschinski M., Arnold R., Goke B., Byrne M.M. Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose. Am J Physiol Endocrinol Metab 2002, 282:E917-E922.
43. Kim J.Y., Goran M.I., Toledo-Corral C.M., Weigensberg M.J., Choi M., Shaibi G.Q. One-hour glucose during an oral glucose challenge prospectively predicts beta-cell deterioration and prediabetes in obese Hispanic youth. Diabetes Care 2013, 36:1681-1686.